Literature DB >> 12846569

Active peptidic mimics of the second intracellular loop of the V(1A) vasopressin receptor are structurally related to the second intracellular rhodopsin loop: a combined 1H NMR and biochemical study.

Hélène Déméné1, Sébastien Granier, Dany Muller, Gilles Guillon, Marie-Noëlle Dufour, Marc-André Delsuc, Marcel Hibert, Robert Pascal, Christiane Mendre.   

Abstract

Vasopressin (VP) receptors belong to the widespread G protein-coupled receptor family. The crucial role of VP receptor intracellular loops in the coupling with the heterotrimeric G proteins was previously demonstrated by construction of a vasopressin receptor chimera. Yet, no fine structural data are available concerning the receptor molecular determinants involved in their interactions with G proteins. In this study, we synthesized both a linear and a cyclic form of the second intracellular loop (i2) of the human V(1a) vasopressin receptor isoform that is important for the interaction between the alphaq/alpha11 G protein and the receptor. These two peptides are biologically active. They specifically inhibit vasopressin binding to the V(1a) receptor, suggesting that the corresponding endogenous peptides contribute to the structure of the vasopressin binding site via intra- or intermolecular interactions with the core of the V(1a) receptor. The i2 peptide structures were determined by (1)H NMR. Both exhibit a helix and helical elements in their N- and C-terminal parts, respectively, separated by a turn imposed by a proline residue. More interestingly, the central Pro-Leu motif conserved in many GPCRs and thought to be important for coupling to G proteins can adopt different conformations. The "U" shape structure of the i2 loop is compatible with its anchoring to transmembrane domains III and IV and is very similar to the shape of bovine rhodopsin i2. Altogether, these data contribute to a better understanding of the structure of a not yet crystallized GPCR using the mimetic peptide approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846569     DOI: 10.1021/bi027358n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Lifting the lid on GPCRs: the role of extracellular loops.

Authors:  M Wheatley; D Wootten; M T Conner; J Simms; R Kendrick; R T Logan; D R Poyner; J Barwell
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Unraveling the structure and function of G protein-coupled receptors through NMR spectroscopy.

Authors:  Irina G Tikhonova; Stefano Costanzi
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

3.  Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).

Authors:  Natalie A Diepenhorst; Emma J Petrie; Catherine Z Chen; Amy Wang; Mohammed Akhter Hossain; Ross A D Bathgate; Paul R Gooley
Journal:  J Biol Chem       Date:  2014-10-28       Impact factor: 5.157

4.  Studies of the molecular mechanisms of action of relaxin on the adenylyl cyclase signaling system using synthetic peptides derived from the LGR7 relaxin receptor.

Authors:  A O Shpakov; I A Gur'yanov; L A Kuznetsova; S A Plesneva; E A Shpakova; G P Vlasov; M N Pertseva
Journal:  Neurosci Behav Physiol       Date:  2007-09

5.  Solution NMR of signal peptidase, a membrane protein.

Authors:  Monika Musial-Siwek; Debra A Kendall; Philip L Yeagle
Journal:  Biochim Biophys Acta       Date:  2007-12-14

6.  Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.

Authors:  Alison C MacKinnon; Uzma Tufail-Hanif; Mark Wheatley; Adriano G Rossi; Christopher Haslett; Michael Seckl; Tariq Sethi
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.